Dr. rer. nat. Peter Linz

Institute of Radiology Interdisziplinäres Zentrum für Klinische Forschung IZKF-Förderlinien

Hemodialysis Patients with Cardiovascular Disease Reveal Increased Tissue Na+ Deposition (2022) Friedrich AC, Linz P, Nagel AM, Rosenhauer D, Horn S, Schiffer M, Uder M, et al. Journal article Tissue sodium content correlates with hypertrophic vascular remodeling in type 2 diabetes (2021) Kannenkeril D, Jung S, Harazny J, Striepe K, Ott C, Dahlmann A, Kopp C, et al. Journal article Reduced tissue sodium content is related to improvement of vascular function in patients with chronic heart failure treated with the SGLT2 inhibitor empagliflozin (2021) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Conference contribution Reduction of Tissue Na+ Accumulation After Renal Transplantation (2021) Dahlmann A, Linz P, Zucker I, Haag V, Jantsch J, Dienemann T, Nagel AM, et al. Journal article Cardiac Phenotype and Tissue Sodium Content in Adolescents with Defects in the Melanocortin System (2021) Puder L, Roth S, Krabusch P, Wiegand S, Opitz R, Bald M, Flück C, et al. Journal article Longitudinal Sodium MRI of Multiple Sclerosis Lesions: Is there Added Value of Sodium Inversion Recovery MRI (2021) Mennecke A, Nagel AM, Huhn K, Linker R, Schmidt M, Rothhammer V, Wilferth T, et al. Journal article Skin sodium is increased in male patients with multiple sclerosis and related animal models (2021) Huhn K, Linz P, Pemsel F, Michalke B, Seyferth S, Kopp C, Chaudri MA, et al. Journal article Responsiveness of afferent renal nerve units in renovascular hypertension in rats (2021) Rodionova K, Hilgers KF, Rafii-Tabrizi S, Doellner J, Cordasic N, Linz P, Karl A, et al. Journal article THE SGLT2 INHIBITOR EMPAGLIFLOZIN REDUCES TISSUE SODIUM CONTENT IN PATIENTS WITH CHRONIC HEART FAILURE (2021) Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al. Conference contribution EFFECTS OF THE SGLT2 INHIBITOR EMPAGLIFLOZIN ON VASCULAR FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE (2021) Kolwelter J, Bosch A, Jung S, Linz P, Kannenkeril D, Nagel AM, Ott C, et al. Conference contribution